{"id":11833,"date":"2026-04-09T02:31:48","date_gmt":"2026-04-09T02:31:48","guid":{"rendered":"https:\/\/pharmamachinecn.com\/?p=11833"},"modified":"2026-03-09T02:34:11","modified_gmt":"2026-03-09T02:34:11","slug":"your-guide-to-21-cfr-part-11-guidelines-for-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/pharmamachinecn.com\/tr\/your-guide-to-21-cfr-part-11-guidelines-for-pharmaceuticals\/","title":{"rendered":"\u0130la\u00e7lar i\u00e7in 21 CFR B\u00f6l\u00fcm 11 Y\u00f6nergeleri K\u0131lavuzunuz"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"11833\" class=\"elementor elementor-11833\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-656075b4 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"656075b4\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-78348194\" data-id=\"78348194\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2b902b66 product-data-tab elementor-widget elementor-widget-text-editor\" data-id=\"2b902b66\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\u0130la\u00e7lar i\u00e7in 21 CFR B\u00f6l\u00fcm 11 y\u00f6nergeleri mevcuttur \u00e7\u00fcnk\u00fc d\u00fczenleyiciler kontrol edilmedi\u011fi, izlenebilir olmad\u0131\u011f\u0131 ve korunmad\u0131\u011f\u0131 s\u00fcrece verilere g\u00fcvenmezler. Eksik bir denetim izi, payla\u015f\u0131lan bir oturum a\u00e7ma veya kontrols\u00fcz bir sistem ciddi bir uyum sorununa d\u00f6n\u00fc\u015febilir.<\/p><figure id=\"attachment_11898\" aria-describedby=\"caption-attachment-11898\" style=\"width: 1000px\" class=\"wp-caption aligncenter\"><img fetchpriority=\"high\" decoding=\"async\" class=\"size-full wp-image-11898\" src=\"https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/04\/21-CFR-Part-11-Guidelines-for-Pharmaceuticals-Define.jpg\" alt=\"21 CFR B\u00f6l\u00fcm 11 \u0130la\u00e7lar i\u00e7in K\u0131lavuzlar Tan\u0131mlay\u0131n\" width=\"1000\" height=\"616\" srcset=\"https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/04\/21-CFR-Part-11-Guidelines-for-Pharmaceuticals-Define.jpg 1000w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/04\/21-CFR-Part-11-Guidelines-for-Pharmaceuticals-Define-300x185.jpg 300w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/04\/21-CFR-Part-11-Guidelines-for-Pharmaceuticals-Define-768x473.jpg 768w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/04\/21-CFR-Part-11-Guidelines-for-Pharmaceuticals-Define-18x12.jpg 18w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/04\/21-CFR-Part-11-Guidelines-for-Pharmaceuticals-Define-600x370.jpg 600w\" sizes=\"(max-width: 1000px) 100vw, 1000px\" \/><figcaption id=\"caption-attachment-11898\" class=\"wp-caption-text\"><em><strong>21 CFR B\u00f6l\u00fcm 11 \u0130la\u00e7lar i\u00e7in K\u0131lavuzlar Tan\u0131mlay\u0131n.<\/strong><\/em><\/figcaption><\/figure><p>Ancak en \u00f6nemli sorun, bir\u00e7ok ila\u00e7 \u015firketinin 21 CFR B\u00f6l\u00fcm 11 ile m\u00fccadele etmesidir \u00e7\u00fcnk\u00fc genellikle yanl\u0131\u015f anla\u015f\u0131lmaktad\u0131r. Baz\u0131lar\u0131 bunun yaz\u0131l\u0131m sat\u0131c\u0131lar\u0131 i\u00e7in ge\u00e7erli oldu\u011funu d\u00fc\u015f\u00fcn\u00fcrken, di\u011ferleri do\u011frulaman\u0131n tek ba\u015f\u0131na yeterli oldu\u011funu varsaymaktad\u0131r.<\/p><p>Bunun tesisinizde ger\u00e7ekle\u015fmedi\u011finden emin olmak i\u00e7in 21 CFR B\u00f6l\u00fcm 11 y\u00f6nergelerinin neler oldu\u011funu ve nas\u0131l uyumlu kalabilece\u011finizi a\u00e7\u0131klayaca\u011f\u0131z.<\/p><h2><strong><b>21 CFR B\u00f6l\u00fcm 11 Nedir?<\/b><\/strong><\/h2><figure id=\"attachment_10754\" aria-describedby=\"caption-attachment-10754\" style=\"width: 624px\" class=\"wp-caption aligncenter\"><img decoding=\"async\" class=\"size-full wp-image-10754\" src=\"https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2025\/12\/The-FDA-headquarters.png\" alt=\"FDA genel merkezi\" width=\"624\" height=\"351\" srcset=\"https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2025\/12\/The-FDA-headquarters.png 624w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2025\/12\/The-FDA-headquarters-300x169.png 300w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2025\/12\/The-FDA-headquarters-18x10.png 18w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2025\/12\/The-FDA-headquarters-600x338.png 600w\" sizes=\"(max-width: 624px) 100vw, 624px\" \/><figcaption id=\"caption-attachment-10754\" class=\"wp-caption-text\"><em><strong>FDA genel merkezi.<\/strong><\/em><\/figcaption><\/figure><p><a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/part-11-electronic-records-electronic-signatures-scope-and-application\" target=\"_blank\" rel=\"noopener\"><u>21 CFR B\u00f6l\u00fcm 11<\/u><\/a>\u00a0elektronik kay\u0131tlar\u0131n ve elektronik imzalar\u0131n nas\u0131l ele al\u0131nmas\u0131 gerekti\u011fini tan\u0131mlayan bir ABD FDA y\u00f6netmeli\u011fidir. Amac\u0131 basittir. Ka\u011f\u0131t yerine elektronik sistemler kullanmay\u0131 tercih ederseniz, FDA'n\u0131n verilere g\u00fcvenebilmesi gerekir.<\/p><p>Y\u00f6netmelik, ila\u00e7 \u015firketlerinin ka\u011f\u0131t kay\u0131tlardan uzakla\u015fmaya ba\u015flamas\u0131yla birlikte y\u00fcr\u00fcrl\u00fc\u011fe girmi\u015ftir.<\/p><p>Denetim izleri, kullan\u0131c\u0131 eri\u015fim kontrolleri, sistem do\u011frulama ve g\u00fcvenli elektronik imzalar gibi kontroller gerektirir. Bu kontroller d\u00fczenleyicilerin kimin ne yapt\u0131\u011f\u0131n\u0131, ne zaman yapt\u0131\u011f\u0131n\u0131 ve verilerin de\u011fi\u015ftirilip de\u011fi\u015ftirilmedi\u011fini do\u011frulamas\u0131na olanak tan\u0131r.<\/p><h2><strong><b>21 CFR B\u00f6l\u00fcm 11 \u0130la\u00e7lar i\u00e7in Bilmeniz Gereken K\u0131lavuzlar<\/b><\/strong><\/h2><p>The <a href=\"https:\/\/www.fda.gov\/media\/75414\/download\" target=\"_blank\" rel=\"noopener\"><u>21 CFR B\u00f6l\u00fcm 11 y\u00f6nergeleri<\/u><\/a>\u00a0FDA'n\u0131n ila\u00e7 \u015firketleri elektronik sistemler kulland\u0131\u011f\u0131nda ne bekledi\u011fini a\u00e7\u0131klar. Bu kurallara uyulmamas\u0131 halinde, elektronik kay\u0131tlara itiraz edilebilir veya bir denetim s\u0131ras\u0131nda reddedilebilir.<\/p><p>A\u015fa\u011f\u0131da her bir temel k\u0131lavuzun pratik bir a\u00e7\u0131klamas\u0131 yer almaktad\u0131r.<\/p><h3><strong><b>1.1 Elektronik Kay\u0131t Gereklilikleri<\/b><\/strong><\/h3><figure id=\"attachment_11836\" aria-describedby=\"caption-attachment-11836\" style=\"width: 627px\" class=\"wp-caption aligncenter\"><img decoding=\"async\" class=\"size-full wp-image-11836\" src=\"https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Electronic-records-requirements.png\" alt=\"Elektronik kay\u0131t gereklilikleri\" width=\"627\" height=\"156\" srcset=\"https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Electronic-records-requirements.png 627w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Electronic-records-requirements-300x75.png 300w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Electronic-records-requirements-18x4.png 18w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Electronic-records-requirements-600x149.png 600w\" sizes=\"(max-width: 627px) 100vw, 627px\" \/><figcaption id=\"caption-attachment-11836\" class=\"wp-caption-text\"><em><strong>Elektronik kay\u0131t gereklilikleri.<\/strong><\/em><\/figcaption><\/figure><p>Bir elektronik kayd\u0131n B\u00f6l\u00fcm 11 kapsam\u0131nda kabul edilebilir olmas\u0131 i\u00e7in ka\u011f\u0131t kay\u0131tla ayn\u0131 \u015fekilde g\u00fcvenilir olmas\u0131 gerekir. Bu, kayd\u0131n do\u011fru, eksiksiz olmas\u0131 ve uygunsuz de\u011fi\u015fikliklerden korunmas\u0131 gerekti\u011fi anlam\u0131na gelir.<\/p><p>Do\u011fruluk, verilerin \u00fcretim, test veya inceleme s\u0131ras\u0131nda ger\u00e7ekte ne oldu\u011funu yans\u0131tmas\u0131 gerekti\u011fi anlam\u0131na gelir. Bir de\u011fer de\u011fi\u015ftirilirse, sistem de\u011fi\u015fikli\u011fi kimin yapt\u0131\u011f\u0131n\u0131, ne zaman yap\u0131ld\u0131\u011f\u0131n\u0131 ve neden yap\u0131ld\u0131\u011f\u0131n\u0131 kaydetmelidir.<\/p><p>Kay\u0131tlar ayr\u0131ca t\u00fcm saklama s\u00fcreleri boyunca okunabilir kalmal\u0131d\u0131r. Bu, net bi\u00e7imlendirme, uygun zaman damgalar\u0131 ve kay\u0131tlar\u0131n y\u0131llar sonra g\u00f6zden ge\u00e7irilebilmesini i\u00e7erir. Sistem eski kay\u0131tlar\u0131 g\u00f6r\u00fcnt\u00fcleyemiyorsa bu gereklili\u011fi yerine getiremiyor demektir.<\/p><h3><strong><b>1.2 Elektronik \u0130mza Gereklilikleri<\/b><\/strong><\/h3><figure id=\"attachment_11837\" aria-describedby=\"caption-attachment-11837\" style=\"width: 627px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-11837\" src=\"https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Electronic-signatures-requirements.png\" alt=\"Elektronik imza gereklilikleri\" width=\"627\" height=\"131\" srcset=\"https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Electronic-signatures-requirements.png 627w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Electronic-signatures-requirements-300x63.png 300w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Electronic-signatures-requirements-18x4.png 18w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Electronic-signatures-requirements-600x125.png 600w\" sizes=\"(max-width: 627px) 100vw, 627px\" \/><figcaption id=\"caption-attachment-11837\" class=\"wp-caption-text\"><em><strong>Elektronik imza gereklilikleri.<\/strong><\/em><\/figcaption><\/figure><p>Elektronik imzalar\u0131n elle at\u0131lan imzalar\u0131n yerini almas\u0131na izin verilmektedir, ancak bu imzalar\u0131n g\u00fcvenli ve tek bir ki\u015fiyle ba\u011flant\u0131l\u0131 olmas\u0131 \u015fart\u0131yla.<\/p><p>Ge\u00e7erli bir elektronik imza, kullan\u0131c\u0131 kimli\u011fi ve parola veya ba\u015fka bir g\u00fcvenli kimlik do\u011frulama y\u00f6ntemi gibi en az iki bile\u015fen i\u00e7ermelidir. Bu imza, kayd\u0131 kimin imzalad\u0131\u011f\u0131n\u0131, hangi kayd\u0131n imzaland\u0131\u011f\u0131n\u0131 ve ne zaman imzaland\u0131\u011f\u0131n\u0131 a\u00e7\u0131k\u00e7a g\u00f6stermelidir.<\/p><p>Yasal olarak elektronik imzalar ba\u011flay\u0131c\u0131d\u0131r. Bu da \u015firketlerin bunlar\u0131n nas\u0131l verildi\u011fini, kullan\u0131ld\u0131\u011f\u0131n\u0131 ve iptal edildi\u011fini kontrol etmesi gerekti\u011fi anlam\u0131na gelir. Payla\u015f\u0131lan hesaplar veya genel oturum a\u00e7ma bilgileri elektronik imzalar\u0131 ge\u00e7ersiz k\u0131lar ve ciddi bir uyum sorunu olarak kabul edilir.<\/p><h3><strong><b>1.3 Denetim \u0130zi Gereksinimleri<\/b><\/strong><\/h3><figure id=\"attachment_11838\" aria-describedby=\"caption-attachment-11838\" style=\"width: 627px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-11838\" src=\"https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Audit-trail-requirements.png\" alt=\"Denetim izi gereksinimleri\" width=\"627\" height=\"278\" srcset=\"https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Audit-trail-requirements.png 627w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Audit-trail-requirements-300x133.png 300w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Audit-trail-requirements-18x8.png 18w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Audit-trail-requirements-600x266.png 600w\" sizes=\"(max-width: 627px) 100vw, 627px\" \/><figcaption id=\"caption-attachment-11838\" class=\"wp-caption-text\"><em><strong>Denetim izi gereksinimleri.<\/strong><\/em><\/figcaption><\/figure><p><a href=\"https:\/\/www.pharmaguideline.com\/2014\/06\/audit-trial-requirements-in-pharmaceuticals.html\" target=\"_blank\" rel=\"noopener\"><u>Denetim izleri<\/u><\/a>\u00a021 CFR B\u00f6l\u00fcm 11'in en kritik k\u0131s\u0131mlar\u0131ndan biridir. M\u00fcfetti\u015fler bir kayd\u0131n ge\u00e7mi\u015fini anlamak i\u00e7in bunlara g\u00fcvenirler.<\/p><p>Bir denetim izi, kullan\u0131c\u0131lar\u0131n devre d\u0131\u015f\u0131 b\u0131rakmas\u0131na veya d\u00fczenlemesine izin vermeden verilerdeki de\u011fi\u015fiklikleri otomatik olarak kaydetmelidir. Bu, de\u011ferlerdeki de\u011fi\u015fiklikleri, silmeleri, \u00fczerine yazmalar\u0131 ve hatta kay\u0131tlar\u0131 de\u011fi\u015ftirmeye y\u00f6nelik ba\u015far\u0131s\u0131z giri\u015fimleri i\u00e7erir.<\/p><p>Her giri\u015f, de\u011fi\u015fikli\u011fi kimin yapt\u0131\u011f\u0131n\u0131, neyin de\u011fi\u015ftirildi\u011fini, ne zaman oldu\u011funu ve bazen nedenini kaydetmelidir. Veri b\u00fct\u00fcnl\u00fc\u011f\u00fc sorunlar\u0131n\u0131 ortaya \u00e7\u0131kard\u0131klar\u0131 i\u00e7in m\u00fcfetti\u015fler denetim izlerini \u00e7ok \u00f6nemserler.<\/p><h3><strong><b>1.4 Kullan\u0131c\u0131 Eri\u015fimi ve G\u00fcvenlik Kontrolleri<\/b><\/strong><\/h3><figure id=\"attachment_11839\" aria-describedby=\"caption-attachment-11839\" style=\"width: 627px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-11839\" src=\"https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Security-controls-requirements.png\" alt=\"G\u00fcvenlik kontrolleri gereksinimleri\" width=\"627\" height=\"284\" srcset=\"https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Security-controls-requirements.png 627w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Security-controls-requirements-300x136.png 300w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Security-controls-requirements-18x8.png 18w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/01\/Security-controls-requirements-600x272.png 600w\" sizes=\"(max-width: 627px) 100vw, 627px\" \/><figcaption id=\"caption-attachment-11839\" class=\"wp-caption-text\"><em><strong>G\u00fcvenlik kontrolleri gereksinimleri.<\/strong><\/em><\/figcaption><\/figure><p>B\u00f6l\u00fcm 11, elektronik sistemlere kimlerin eri\u015febilece\u011fi ve hangi eylemleri ger\u00e7ekle\u015ftirebilecekleri konusunda s\u0131k\u0131 kontrol gerektirir.<\/p><p>Her kullan\u0131c\u0131n\u0131n benzersiz bir kullan\u0131c\u0131 kimli\u011fi olmal\u0131d\u0131r. Parolalar korunmal\u0131 ve d\u00fczenli olarak y\u00f6netilmelidir. Kullan\u0131c\u0131lar\u0131n yaln\u0131zca kendi i\u015fleriyle ilgili g\u00f6revleri yerine getirebilmeleri i\u00e7in rol tabanl\u0131 eri\u015fim beklenmektedir. \u00d6rne\u011fin, operat\u00f6rler kay\u0131tlar\u0131 onaylamamal\u0131 ve g\u00f6zden ge\u00e7irenler ham verileri de\u011fi\u015ftirmemelidir.<\/p><p>Payla\u015f\u0131lan giri\u015fler bu y\u00f6nergeyi do\u011frudan ihlal eder. Birden fazla ki\u015fi ayn\u0131 hesab\u0131 kulland\u0131\u011f\u0131nda, sorumlulu\u011fu kan\u0131tlamak imkans\u0131z hale gelir.<\/p><h3><strong><b>1.5 Sistem Do\u011frulama Beklentileri<\/b><\/strong><\/h3><p>Do\u011frulama, bir sistemin \u00f6zel kullan\u0131m\u0131 i\u00e7in ama\u00e7land\u0131\u011f\u0131 gibi \u00e7al\u0131\u015ft\u0131\u011f\u0131n\u0131 kan\u0131tlamak i\u00e7in gereklidir. Bir sat\u0131c\u0131n\u0131n bir sistemin a\u015fa\u011f\u0131daki \u00f6zelliklere sahip oldu\u011funu iddia etmesi yeterli de\u011fildir <strong>\u201cB\u00f6l\u00fcm 11 uyumlu.\u201d<\/strong><\/p><p>\u015eirketler sistemleri kullan\u0131m amac\u0131na g\u00f6re do\u011frulamal\u0131d\u0131r. Bu, gereksinimlerin belgelenmesini, temel i\u015flevlerin test edilmesini, g\u00fcvenlik kontrollerinin do\u011frulanmas\u0131n\u0131 ve denetim izi davran\u0131\u015f\u0131n\u0131n onaylanmas\u0131n\u0131 i\u00e7erir.<\/p><p>Bu do\u011frulama, sistemin ve ilgili t\u00fcm sistemlerin <a href=\"https:\/\/pharmamachinecn.com\/tr\/gxp-in-pharmaceutical-industry-a-complete-compliance-guide\/\"><u>GxP s\u00fcre\u00e7leri<\/u><\/a>\u00a0s\u00fcrekli olarak do\u011fru performans g\u00f6stermesi gerekir. M\u00fcfetti\u015fler sistemlerin kontrol alt\u0131nda kald\u0131\u011f\u0131n\u0131 teyit etmek i\u00e7in genellikle do\u011frulama belgelerini g\u00f6zden ge\u00e7irirler.<\/p><h3><strong><b>1.6 Kay\u0131t Saklama ve Geri Alma<\/b><\/strong><\/h3><p>Elektronik kay\u0131tlar, GMP y\u00f6netmelikleri uyar\u0131nca ka\u011f\u0131t kay\u0131tlar i\u00e7in gereken s\u00fcre boyunca saklanmal\u0131d\u0131r. Bu s\u00fcre zarf\u0131nda kay\u0131tlar g\u00fcvenli, okunabilir ve eri\u015filebilir durumda kalmal\u0131d\u0131r.<\/p><p>Geri alma da en az depolama kadar \u00f6nemlidir. M\u00fcfetti\u015fler denetimler s\u0131ras\u0131nda kay\u0131tlar\u0131n h\u0131zl\u0131 ve eksiksiz bir \u015fekilde \u00fcretilmesini bekler. Herhangi bir gecikme, eksik veri veya okunamayan dosyalar varsa, bunlar hemen k\u0131rm\u0131z\u0131 bayraklar\u0131 y\u00fckseltir.<\/p><h2><strong><b>Hangi Sistemler 21 CFR B\u00f6l\u00fcm 11 Y\u00f6nergelerine Uymal\u0131d\u0131r?<\/b><\/strong><\/h2><p>21 CFR B\u00f6l\u00fcm 11 y\u00f6nergeleri, a\u015fa\u011f\u0131dakileri kar\u015f\u0131lamak i\u00e7in kullan\u0131lan elektronik kay\u0131tlar\u0131 olu\u015fturan, de\u011fi\u015ftiren, muhafaza eden veya depolayan t\u00fcm sistemler i\u00e7in ge\u00e7erlidir <a href=\"https:\/\/pharmamachinecn.com\/tr\/gmp-for-pharmaceutical-manufacturing\/\"><u>GMP gereklilikleri<\/u><\/a>. Sistemin t\u00fcr\u00fc, nas\u0131l kullan\u0131ld\u0131\u011f\u0131ndan daha az \u00f6nemlidir.<\/p><p>Bir sistem \u00fcr\u00fcn kalitesi, g\u00fcvenli\u011fi veya uygunlu\u011fu ile ilgili kararlar\u0131 destekliyorsa, B\u00f6l\u00fcm 11 ge\u00e7erlidir. Bu yayg\u0131n sistemlerden baz\u0131lar\u0131 \u015funlard\u0131r:<\/p><ul><li><b><\/b><strong><b>\u00dcretim Y\u00fcr\u00fctme Sistemleri<\/b><\/strong>: MES sistemleri parti y\u00fcr\u00fctmeyi, s\u00fcre\u00e7 parametrelerini ve \u00fcretim kay\u0131tlar\u0131n\u0131 y\u00f6netir. Kay\u0131tlar ka\u011f\u0131t parti kay\u0131tlar\u0131n\u0131n yerini ald\u0131\u011f\u0131 i\u00e7in, B\u00f6l\u00fcm 11 kontrolleri zorunludur.<\/li><li><b><\/b><strong><b>Laboratuvar Bilgi Y\u00f6netim Sistemleri<\/b><\/strong>: LIMS sistemleri test sonu\u00e7lar\u0131n\u0131, hesaplamalar\u0131 ve onaylar\u0131 depolar. Serbest b\u0131rakma veya stabilite i\u00e7in kullan\u0131lan t\u00fcm elektronik laboratuvar verileri B\u00f6l\u00fcm 11 gerekliliklerini kar\u015f\u0131lamal\u0131d\u0131r.<\/li><li><b><\/b><strong><b>Kalite Y\u00f6netim Sistemleri<\/b><\/strong>: KYS platformlar\u0131 sapmalar\u0131, CAPA'lar\u0131, de\u011fi\u015fiklik kontrollerini ve onaylar\u0131 ele al\u0131r. Bu kay\u0131tlar d\u00fczenleyici kan\u0131tlar oldu\u011fundan, B\u00f6l\u00fcm 11 ge\u00e7erlidir.<\/li><li><b><\/b><strong><b>Yaz\u0131l\u0131m ve G\u00f6m\u00fcl\u00fc Sistemler<\/b><\/strong>: Bir\u00e7ok \u00fcretim ve laboratuvar cihaz\u0131 elektronik veri \u00fcretir. Bu veriler GMP kararlar\u0131 i\u00e7in kullan\u0131l\u0131yorsa, sistem eri\u015fim kontrol\u00fcne, denetim izlerine ve do\u011frulamaya sahip olmal\u0131d\u0131r.<\/li><li><b><\/b><strong><b>Elektronik Tablolar ve \u00d6zel Ara\u00e7lar<\/b><\/strong>: Elektronik tablolar genellikle g\u00f6z ard\u0131 edilir. Sonu\u00e7lar\u0131 hesaplamak, verileri izlemek veya kararlar\u0131 desteklemek i\u00e7in kullan\u0131l\u0131yorlarsa, B\u00f6l\u00fcm 11'e tabidirler.<\/li><\/ul><h2><strong><b>21 CFR B\u00f6l\u00fcm 11 Y\u00f6nergeleri Hakk\u0131nda Yayg\u0131n Yanl\u0131\u015f Anlamalar<\/b><\/strong><\/h2><p>21 CFR B\u00f6l\u00fcm 11 ile ba\u011flant\u0131l\u0131 bir\u00e7ok uyum sorunu sistem veya teknoloji eksikli\u011finden kaynaklanmamaktad\u0131r. Bunlar yanl\u0131\u015f varsay\u0131mlardan kaynaklan\u0131r. Bu nedenle, daha sonra ciddi sonu\u00e7lar\u0131 \u00f6nlemeye yard\u0131mc\u0131 olmak i\u00e7in bu yanl\u0131\u015f anlamalar\u0131 erkenden a\u00e7\u0131kl\u0131\u011fa kavu\u015fturmak daha iyidir.<\/p><h3><strong><b>1. Sat\u0131c\u0131m\u0131z B\u00f6l\u00fcm 11 Uyumlulu\u011funu Sa\u011flar.<\/b><\/strong><\/h3><p>Bu en yayg\u0131n hatalardan biridir. Sat\u0131c\u0131lar, denetim izleri ve eri\u015fim kontrolleri gibi B\u00f6l\u00fcm 11'e haz\u0131r \u00f6zelliklere sahip sistemler sa\u011flayabilir. Ancak, uyumlulu\u011fun sahibi de\u011fillerdir.<\/p><p>Sistemi kullanan ila\u00e7 \u015firketi do\u011frulama, kullan\u0131c\u0131 y\u00f6netimi, prosed\u00fcrler ve s\u00fcrekli kontrolden sorumludur.<\/p><h3><strong><b>2. \u201cSistem Onaylan\u0131rsa Uyumluyuz.<\/b><\/strong><\/h3><p><a href=\"https:\/\/pharmamachinecn.com\/tr\/what-is-pharmaceutical-process-validation\/\"><u>Do\u011frulama<\/u><\/a>\u00a0gereklidir, ancak tek ba\u015f\u0131na yeterli de\u011fildir. Eri\u015fim zay\u0131f bir \u015fekilde kontrol ediliyorsa, denetim izleri g\u00f6zden ge\u00e7irilmiyorsa veya prosed\u00fcrler eksikse, onaylanm\u0131\u015f bir sistem yine de B\u00f6l\u00fcm 11'de ba\u015far\u0131s\u0131z olabilir.<\/p><p>B\u00f6l\u00fcm 11 tek seferlik bir do\u011frulama faaliyeti de\u011fil, s\u00fcrekli kontrol bekler. M\u00fcfetti\u015fler sistemin her g\u00fcn nas\u0131l kullan\u0131ld\u0131\u011f\u0131na bakarlar.<\/p><h3><strong><b>3. \u201cB\u00f6l\u00fcm 11 Yaln\u0131zca B\u00fcy\u00fck Sistemler \u0130\u00e7in Ge\u00e7erlidir.\u201d<\/b><\/strong><\/h3><p>B\u00f6l\u00fcm 11, boyutuna bak\u0131lmaks\u0131z\u0131n GMP veya d\u00fczenleyici kararlar i\u00e7in kullan\u0131lan t\u00fcm sistemler i\u00e7in ge\u00e7erlidir. K\u00fc\u00e7\u00fck ara\u00e7lar, elektronik tablolar veya g\u00f6m\u00fcl\u00fc ekipman yaz\u0131l\u0131mlar\u0131 genellikle g\u00f6z ard\u0131 edilir.<\/p><p>Bir sistem \u00fcr\u00fcn kalitesini veya s\u00fcr\u00fcm\u00fcn\u00fc desteklemek i\u00e7in kullan\u0131lan elektronik kay\u0131tlar\u0131 olu\u015fturur veya de\u011fi\u015ftirirse, B\u00f6l\u00fcm 11 gereklilikleri uygulan\u0131r.<\/p><h3><strong><b>4. \u201cPayla\u015f\u0131lan Kullan\u0131c\u0131 Hesaplar\u0131 Kabul Edilebilir\u201d<\/b><\/strong><\/h3><p>Payla\u015f\u0131lan oturum a\u00e7ma bilgileri ciddi bir ihlaldir. B\u00f6l\u00fcm 11, hesap verebilirli\u011fi ve izlenebilirli\u011fi sa\u011flamak i\u00e7in benzersiz kullan\u0131c\u0131 kimli\u011fi gerektirir.<\/p><p>Birden fazla ki\u015fi kimlik bilgilerini payla\u015ft\u0131\u011f\u0131nda, kimin hareket etti\u011fini kan\u0131tlamak imkans\u0131z hale gelir. Veri b\u00fct\u00fcnl\u00fc\u011f\u00fcne zarar verdi\u011fi i\u00e7in m\u00fcfetti\u015fler bu sorunu rutin olarak dile getirmektedir.<\/p><h2><strong><b>SSS<\/b><\/strong><\/h2><h3><strong><b>1. FDA'ya g\u00f6re bir \u201cElektronik Kay\u0131t\u201d neyi tan\u0131mlar?<\/b><\/strong><\/h3><p>Elektronik kay\u0131t, bir bilgisayar sistemi taraf\u0131ndan i\u015flenen dijital formda temsil edilen metin, grafik, veri, ses veya resimsel bilgilerin herhangi bir kombinasyonudur. \u0130la\u00e7 \u015firketleri i\u00e7in bu, laboratuvar sonu\u00e7lar\u0131 ve parti kay\u0131tlar\u0131ndan kalite denetimleri ve klinik ara\u015ft\u0131rma verilerine kadar her \u015feyi i\u00e7erir.<\/p><h3><strong><b>2. Bir \u0130mza Beyannamesinde hangi bilgiler g\u00f6r\u00fcn\u00fcr olmal\u0131d\u0131r?<\/b><\/strong><\/h3><p>Bir elektronik imza uyguland\u0131\u011f\u0131nda, sistem imzalayan ki\u015finin bas\u0131l\u0131 ad\u0131n\u0131, imzan\u0131n at\u0131ld\u0131\u011f\u0131 tarih ve saati ve imzan\u0131n yazarl\u0131k veya onay gibi anlam\u0131n\u0131 a\u00e7\u0131k\u00e7a g\u00f6stermelidir. Bu meta veri, de\u011fi\u015ftirilememesi veya kald\u0131r\u0131lamamas\u0131 i\u00e7in elektronik kayda kal\u0131c\u0131 olarak ba\u011flanmal\u0131d\u0131r.<\/p><h3><strong><b>3. \u0130la\u00e7 \u015firketleri payla\u015f\u0131lan oturum a\u00e7ma bilgilerini nas\u0131l ele almal\u0131d\u0131r?<\/b><\/strong><\/h3><p>Payla\u015f\u0131lan veya genel oturum a\u00e7ma kimlik bilgilerinin kullan\u0131m\u0131, bireysel hesap verebilirli\u011fi ortadan kald\u0131rd\u0131\u011f\u0131 i\u00e7in 21 CFR B\u00f6l\u00fcm 11 kapsam\u0131nda kesinlikle yasakt\u0131r. Sistemdeki t\u00fcm eylemlerin belirli bir ki\u015fi taraf\u0131ndan izlenebilmesini sa\u011flamak i\u00e7in her kullan\u0131c\u0131 benzersiz bir kimlik kodu ve \u015fifre kombinasyonuna sahip olmal\u0131d\u0131r.<\/p><h2><strong><b>Uyumlulu\u011fun \u00dcretim Alan\u0131nda \u0130\u015fe Yaramas\u0131n\u0131 Sa\u011flay\u0131n<\/b><\/strong><\/h2><p>\u0130la\u00e7lar i\u00e7in 21 CFR B\u00f6l\u00fcm 11 y\u00f6nergelerine yaln\u0131zca yaz\u0131l\u0131mla uyulamaz. Ekipman\u0131n nas\u0131l kuruldu\u011funa, sistemlerin nas\u0131l kullan\u0131ld\u0131\u011f\u0131na ve insanlar\u0131n her g\u00fcn nas\u0131l e\u011fitildi\u011fine ba\u011fl\u0131d\u0131r.<\/p><p>Finetech'te \u00fcreticileri makinelerin \u00f6tesinde destekliyoruz. Yard\u0131m ediyoruz <a href=\"https:\/\/pharmamachinecn.com\/tr\/machine-installation-and-commissioning-at-site\/\"><u>ekipman kurulumu<\/u><\/a>\u00a0Do\u011fru, <a href=\"https:\/\/pharmamachinecn.com\/tr\/machine-operation-training\/\"><u>tren operat\u00f6rleri<\/u><\/a>, verimli \u00fcretim hatlar\u0131 tasarlar ve operasyonlar\u0131 istikrarl\u0131 ve denetime haz\u0131r tutmak i\u00e7in s\u00fcrekli teknik destek sa\u011flar.<\/p><p>Yeni bir hat planl\u0131yorsan\u0131z, mevcut ekipman\u0131 y\u00fckseltiyorsan\u0131z veya uyumluluk zorluklar\u0131yla kar\u015f\u0131 kar\u015f\u0131yaysan\u0131z, ekibimiz 30 y\u0131l\u0131 a\u015fk\u0131n deneyimiyle size yard\u0131mc\u0131 olmak i\u00e7in burada.<\/p><p><a href=\"https:\/\/pharmamachinecn.com\/tr\/contact-us\/\"><em><u><i>Bug\u00fcn Finetech ile ileti\u015fime ge\u00e7in<\/i><\/u><\/em><\/a><em><i>\u00a0\u00fcretim ihtiya\u00e7lar\u0131n\u0131z\u0131 g\u00f6r\u00fc\u015fmek i\u00e7in!<\/i><\/em><\/p><h2><strong>Referanslar:<\/strong><\/h2><p><a href=\"https:\/\/www.anritsu.com\/en-au\/product-inspection\/knowledge-center\/technical-note-2\/2019-03\" target=\"_blank\" rel=\"noopener\"><em><strong>21 CFR B\u00f6l\u00fcm 11 Veri Y\u00f6netimi, Veri B\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fcn temelini olu\u015fturur<\/strong><\/em><\/a>.<\/p><p><a href=\"https:\/\/www.malvernpanalytical.com\/en\/products\/industry-standards\/21-cfr-part-11\" target=\"_blank\" rel=\"noopener\"><span style=\"text-decoration: underline;\"><em><strong>21 CFR B\u00f6l\u00fcm 11 Tam G\u00fcven. Mutlak D\u00fcr\u00fcstl\u00fck.<\/strong><\/em><\/span><\/a><\/p><p><a href=\"https:\/\/learn.microsoft.com\/en-us\/compliance\/regulatory\/offering-fda-cfr-title-21-part-11\" target=\"_blank\" rel=\"noopener\"><span style=\"text-decoration: underline;\"><em><strong>G\u0131da ve \u0130la\u00e7 \u0130daresi CFR Ba\u015fl\u0131k 21 B\u00f6l\u00fcm 11<\/strong><\/em><\/span><\/a>.<\/p><h2><b>Telif Hakk\u0131 Uyar\u0131s\u0131:\u00a0<\/b><\/h2><p>Finetech Group'un \u00f6nceden a\u00e7\u0131k yaz\u0131l\u0131 onay\u0131 olmadan bu web sitesindeki herhangi bir i\u00e7eri\u011fi \u00e7o\u011faltamaz, de\u011fi\u015ftiremez, yay\u0131nlayamaz, g\u00f6r\u00fcnt\u00fcleyemez, iletemez veya herhangi bir \u015fekilde istismar edemezsiniz veya bu t\u00fcr i\u00e7eri\u011fi herhangi bir veritaban\u0131 olu\u015fturmak i\u00e7in kullanamazs\u0131n\u0131z. \u0130\u00e7eri\u011fi kullanma izni i\u00e7in l\u00fctfen ileti\u015fime ge\u00e7in: <a href=\"mailto:info@pharmamachinecn.com\"><span style=\"text-decoration: underline;\">info@pharmamachinecn.com<\/span><\/a><\/p><h2><b>Yasal Uyar\u0131:<\/b><\/h2><p>Bu makalede yer alan bilgiler yaln\u0131zca genel bilgilendirme ama\u00e7l\u0131d\u0131r. \u015eirket, herhangi bir bilginin do\u011frulu\u011funu, g\u00fcncelli\u011fini veya eksiksizli\u011fini garanti etmez ve \u015eirket, bu makalenin i\u00e7eri\u011findeki hatalar veya eksiklikler i\u00e7in hi\u00e7bir sorumluluk kabul etmez.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>21 CFR Part 11 guidelines for pharmaceuticals exist because regulators do not trust data unless it is controlled, traceable, and [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":11898,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[65],"tags":[],"class_list":["post-11833","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-manufacturers"],"acf":[],"_links":{"self":[{"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/posts\/11833","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/comments?post=11833"}],"version-history":[{"count":10,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/posts\/11833\/revisions"}],"predecessor-version":[{"id":12846,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/posts\/11833\/revisions\/12846"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/media\/11898"}],"wp:attachment":[{"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/media?parent=11833"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/categories?post=11833"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/tags?post=11833"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}